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After ligand binding and endocytosis, cell surface receptors can continue to signal from endosomal compartments until
sequestered from the cytoplasm. An important mechanism for receptor downregulation in vivo is via the inward budding of
receptors into intralumenal vesicles to form specialized endosomes called multivesicular bodies (MVBs) that subsequently fuse
with lysosomes, degrading their cargo. This process requires four heterooligomeric protein complexes collectively termed the
ESCRT machinery. In yeast, ESCRT-I is a heterotetrameric complex comprised of three conserved subunits and a fourth subunit
for which identifiable metazoan homologs were lacking. Using C. elegans, we identify MVB-12, a fourth metazoan ESCRT-I
subunit. Depletion of MVB-12 slows the kinetics of receptor downregulation in vivo, but to a lesser extent than inhibition of
other ESCRT-I subunits. Consistent with these findings, targeting of MVB-12 to membranes requires the other ESCRT-I subunits,
but MVB-12 is not required to target the remaining ESCRT-I components. Both endogenous and recombinant ESCRT-I are stable
complexes with a 1:1:1:1 subunit stoichiometry. MVB-12 has two human homologs that co-localize and co-immunoprecipitate
with the ESCRT-I component TSG101. Thus, MVB-12 is a conserved core component of metazoan ESCRT-I that regulates its
activity during MVB biogenesis.
Citation: Audhya A, McLeod IX, Yates JR III, Oegema K (2007) MVB-12, a Fourth Subunit of Metazoan ESCRT-I, Functions in Receptor
Downregulation. PLoS ONE 2(9): e956. doi:10.1371/journal.pone.0000956
INTRODUCTION
The binding of mitogenic growth factors to cell surface receptors
in eukaryotic cells initiates signaling cascades that influence
fundamental processes including cell survival, proliferation,
differentiation, metabolism, and migration [1,2]. Constitutive
signaling can result in a variety of developmental abnormalities
and tumorigenesis [3], indicating that in addition to receptor
activation, cellular homeostasis also requires receptor down-
regulation and degradation. Although ligand binding leads to
receptor endocytosis, signaling can continue from endosomal
compartments until receptors are sequestered from the cytoplasm
[4–7]. An important mechanism for downregulation therefore
occurs via the inward budding of receptors on endosomal
membranes to form intralumenal vesicles in specialized endosomes
called multivesicular bodies (MVBs) that subsequently fuse with
lysosomes, degrading their cargo [5]. This process requires four
heterooligomeric protein complexes (ESCRT-0, -I, -II, -III),
collectively termed the ESCRT machinery [8,9], that facilitate the
trafficking of mono-ubiquitylated proteins, the major substrates of
the MVB pathway [5,8,10]. The subsequent release of ESCRT-I, -
II, and -III from membranes requires the AAA-type ATPase Vps4,
which catalyzes the recycling of ESCRT components for subsequent
rounds of cargo selection and sorting [11–13]. In addition to their
role in receptor downregulation, many components of the ESCRT
machinery have been implicated in the budding of retroviruses such
as HIV from the plasma membrane, a process that is topologically
similar to the budding of endosomal membranes away from the
cytoplasm to form intralumenal vesicles [14,15].
ESCRT-I is a core component of the ESCRT machinery that
functions both in the MVB pathway and retroviral budding. In the
MVB pathway, ESCRT-I functions early, along with ESCRT-
0 and -II, in the recognition and sorting of mono-ubiquitylated
cargo and the formation of intralumenal vesicles. In budding yeast,
ESCRT-I was originally characterized as a heterotrimeric com-
plex containing three proteins Vps23p, Vps28p, and Vps37p, that
all have clearly conserved metazoan orthologs [16]. Disruption of
any of these broadly conserved ESCRT-I components results in
a severe phenotype in which morphologically normal MVBs fail to
form. Recently, a fourth yeast ESCRT-I subunit, Mvb12p, whose
deletion results in a less severe phenotype characterized by a partial
sorting defect was described [17–20]. Unlike other ESCRT-I
components, Mvb12p lacks clear homologs in metazoans.
However, both yeast and mammalian ESCRT-I exhibit similar
sizing profiles by gel filtration chromatography [16,20,21],
suggesting that metazoans may also possess a fourth subunit.
Here, we use C. elegans to identify and functionally characterize
a new subunit of metazoan ESCRT-I. In addition to the three
conserved subunits (TSG-101, VPS-28, and VPS-37), tandem
affinity purification of VPS-37 revealed the presence of a fourth C.
elegans ESCRT-I subunit that we name MVB-12. MVB-12 is
conserved among metazoans, but is ,3 fold larger and bears no
clear sequence similarity to the yeast protein Mvb12p. Hydrody-
namic analysis of endogenous and recombinant ESCRT-I reveals
that both are stable heterotetrameric complexes, with a native
molecular weight of ,125 kD, reflecting a 1:1:1:1 association of
the four subunits. Depletion of MVB-12 slows the kinetics of cell
surface receptor downregulation, consistent with a function in
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homologs of MVB-12, MVB12A and MVB12B, that both
associate with human ESCRT-I in vivo. Together, our data
indicate that metazoans, like yeast, possess a fourth subunit that
regulates ESCRT-I function.
RESULTS
ESCRT-I functions in the downregulation of cell
surface proteins in C. elegans
In C. elegans, oocyte ovulation and fertilization is accompanied by
a series of membrane remodeling events [22] that include the
internalization and subsequent degradation of several cell surface
markers including the LDL-like yolk receptor RME-2 and CAV-1,
a member of the caveolin protein family [23,24]. The reproducible
kinetics of these events with respect to ovulation makes this an
excellent system to define the molecular components necessary for
the downregulation and subsequent degradation of cell surface
proteins. To study the contribution of the ESCRT machinery to
the downregulation of cell surface proteins in C. elegans, we began
by examining the role of ESCRT-I, a heterooligomeric complex
required for the internalization of cell surface proteins into
intralumenal vesicles to form specialized endosomes called multi-
vesicular bodies (MVBs) that fuse with lysosomes to degrade their
cargo. Blast searches identified C. elegans homologs for each of the
three components of the ESCRT-I complex previously shown to
be conserved between yeast and humans (Fig. 1A). To characterize
the role of ESCRT-I in the dynamics of cell surface proteins
during the oocyte to embryo transition, we began by analyzing
GFP:CAV-1. In control oocytes prior to fertilization, GFP:CAV-1
is concentrated in intracellular vesicles and large ring-like
cytoplasmic structures as well as localizing weakly to the plasma
membrane (Fig. 1C, control, -1 oocyte). Immediately after oocytes
pass through the spermatheca and are fertilized, the amount of
GFP:CAV-1 on the cell surface rapidly increases, followed by its
internalization and degradation [23]. Since, adult C. elegans
hermaphrodites ovulate approximately every 20 minutes [25],
examination of the string of newly fertilized embryos present in an
adult worm provides a convenient means of monitoring the
timecourse of the changes in the GFP:CAV-1 distribution. Newly
fertilized embryos exhibited bright GFP:CAV-1 fluorescence,
initially at the cell surface and subsequently on internal
membranes (Fig. 1C, control, +1 embryo), but embryos beyond
the 2-cell stage, approximately 90 minutes post fertilization, lacked
Figure 1. ESCRT-I components mediate degradation of the cell surface protein GFP:CAV-1 after its internalization. (A) Table listing the known
subunits of ESCRT-I in S. cerevisiae, H. sapiens and C. elegans.( B) Schematic of the reproductive system of the adult C. elegans hermaphrodite. Oocytes
(blue) aligned in a row are fertilized in a sequential conveyor belt-like fashion with one ovulation event occurring ,every 20 minutes [25]. Pre-
fertilization oocytes are numbered -1, -2, etc. with respect to their position relative to the spermatheca. Similarly, fertilized embryos (green), which are
at progressively later stages in development as their distance from the spermatheca increases, are numbered +1, +2, +3, etc. (C) Spinning disk
confocal optics were used to image anesthetized control (n=14), tsg-101(RNAi) (n=15), vps-28(RNAi) (n=11), and vps-37(RNAi) (n=10) adult
hermaphrodites expressing GFP:CAV-1. Both differential interference contrast (DIC, left) and fluorescence (right) images are shown. Schematics in the
center column are traces of the DIC images in which the location of the spermatheca (red), the unfertilized oocytes (blue) and the embryos (green)
are highlighted. Boxes indicate the presence of embryos at or beyond the two-cell stage, where GFP:CAV-1 is normally absent. Scale bar is 25 mm.
doi:10.1371/journal.pone.0000956.g001
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depletions of the three conserved ESCRT-I components did not
affect the post-fertilization increase in the amount of GFP:CAV-1
on the cell surface or its subsequent re-internalization. However,
embryos depleted of each component exhibited a substantial delay
in the degradation of internalized GFP:CAV-1, which remained
on internal membranes well beyond the two cell stage (Fig. 1C).
We also observed similar inhibition of the degradation of
internalized RME-2:GFP (described in detail in Fig. 4 below).
We conclude that the C. elegans ESCRT-I complex has a conserved
role in the degradation of internalized cell surface proteins that can
be conveniently visualized by monitoring the fate of proteins
normally targeted for degradation following fertilization.
Identification of MVB-12, a fourth subunit of
C. elegans ESCRT-I
Recent work in budding yeast identified a fourth ESCRT-I
subunit, Mvb12p, for which no metazoan orthologs have yet been
identified (Fig. 1A; [17–20]). To determine whether C. elegans
ESCRT-I also possesses an additional subunit, we purified the
complex from embryos stably expressing a tandem affinity-tagged
form of VPS-37 (Fig. 2A). Analysis of the eluted proteins by mass
spectrometry identified each of the known ESCRT-I subunits and
one additional protein, which we will refer to as MVB-12, at
relatively high sequence coverage (Fig. 2B). In contrast to RNAi-
mediated depletion of the other ESCRT-I subunits, which leads to
Figure 2. Identification of a fourth C. elegans ESCRT-I subunit. (A) A fusion of VPS-37 with a GFP containing tandem affinity purification tag
(GFP
LAP:VPS-37) was isolated from embryo extracts by immunoprecipitation with anti-GFP antibodies. After protease cleavage to remove the GFP
tag, proteins were re-isolated on S-protein agarose and eluted. A silver stained gel of the eluted proteins is shown. Arrowheads indicate the predicted
mobility of the proteins identified by mass spectrometry. (B) Table summarizing the percent sequence coverage, predicted molecular weight, and
RNAi phenotype for each of the four specific proteins in the eluate identified by solution mass spectrometry. For VPS-37, the predicted size including
the additional mass of the affinity purification tag is shown in parentheses. In addition to the four proteins shown, a common contaminant (LEV-11)
was also identified by mass spectrometry, but is not included in the table. (C) Western blots of extracts prepared from wild type worms or worms
specifically depleted of MVB-12 by RNAi. Serial dilutions of extract prepared from untreated worms were loaded to quantify depletion levels. (D)
Spinning disk confocal optics were used to image GFP:MVB-12 in control (n=15), vps-4(RNAi) (n=13), and vps-4, tsg-101(RNAi) (n=15) embryos in
utero. Schematic illustrates the effect of depleting VPS-4, the AAA-ATPase required to recycle endosome-associated ESCRT-I, returning it to the
cytoplasm (lower right). Scale bar is 10 mm. (E) Spinning disk confocal optics were used to image GFP:VPS-37 in control (n=10), vps-4(RNAi) (n=8),
vps-4, tsg-101(RNAi) (n=9), and vps-4, mvb-12(RNAi) (n=9) embryos in utero. Scale bar is 10 mm.
doi:10.1371/journal.pone.0000956.g002
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5% of endogenous levels (Fig. 2C) failed to affect embryo viability
(Fig. 2B), suggesting that MVB-12 is a non-essential component of
ESCRT-I. Consistent with this finding, worms homozygous for
a deletion allele of mvb-12, tm2949, encoding only the first 83 out of
277 amino acids, are viable.
In mammalian cells, ESCRT-I subunits are primarily cytosolic,
being only transiently recruited to endosomal membranes followed
by rapid release that requires the AAA-type ATPase hVPS4 [11–
13]. Consistent with this, GFP fusions with VPS-37 and MVB-12
were primarily cytoplasmic in developing oocytes and embryos,
and were only occasionally found to associate with a small
population of intracellular punctate structures (Fig. 2D, E). Upon
depletion of the C. elegans Vps4 homolog (VPS-4), however, the
GFP fusions with both MVB-12 and VPS-37 strongly accumulated
on endosomal membranes, consistent with a requirement for VPS-
4 in their disassociation (Fig. 2D, E).
The three broadly conserved components of ESCRT-I are
interdependent for their localization to endosomal membranes
[21]. In yeast, Mvb12p requires other ESCRT-I components for
its endosomal localization [17–20]. To test whether MVB-12
requires the presence of other ESCRT-I subunits to associate with
membranes in C. elegans, we compared the distribution of
GFP:MVB-12 in embryos co-depleted of TSG-101 and VPS-4
to that in embryos depleted of VPS-4 alone. In contrast to the
dramatic accumulation of GFP:MVB-12 on membranes in VPS-4
depleted embryos, GFP:MVB-12 remained cytoplasmic in em-
bryos that were simultaneously depleted of TSG-101 (Fig. 2D).
Similarly, a GFP fusion with VPS-37 also remained cytoplasmic in
embryos co-depleted of TSG-101 and VPS-4 (Fig. 2E). In contrast,
simultaneous depletion of MVB-12 with VPS-4 failed to prevent
the accumulation of GFP:VPS-37 on membranes (Fig. 2E).
Together, these data indicate that MVB-12 requires other
ESCRT-I subunits for membrane association, but is itself
dispensable for targeting of the remaining ESCRT-I subunits.
ESCRT-I subunits form a 1:1:1:1 complex in vivo and
in vitro
Analysis of ESCRT-I in extracts of yeast and human cells
fractionated by gel filtration chromatography have shown that
ESCRT-I migrates at a position corresponding to a globular
complex of between 300–450 kDa, raising the possibility that
ESCRT-I oligomerizes in extracts [17–21]. More recently
however, characterization of the yeast ESCRT-I complex by
sedimentation equilibrium centrifugation indicated that it is
a heterotetramer of four subunits in a 1:1:1:1 ratio [20]. To
determine whether ESCRT-I oligomerizes in extracts, or whether
it simply has an elongated shape that causes it to appear large on
gel filtration when compared to globular standards, we compared
the hydrodynamic properties of recombinant C. elegans ESCRT-I
to those of the complex present in extracts. Gel filtration
chromatography and sucrose density gradients were used to
measure the Stokes radii and Sedimentation Values (S-values),
respectively, of the native and recombinant complexes, and these
values were combined [26] to obtain an accurate estimate of the
native molecular weight for each complex.
We began by analyzing recombinant complexes purified after
co-expression of multiple ESCRT-I subunits from polycistronic
vectors in bacteria. A 6xHis tag fused to the C-terminus of TSG-
101 was added to allow complex purification by nickel affinity
chromatography. Co-expression of the C. elegans homologs of the
three previously described metazoan ESCRT-I subunits (TSG-
101, VPS-28, and VPS-37) yielded a single complex with an
estimated native molecular weight of ,88 kDa, consistent with
a 1:1:1 heterotrimeric complex (Stokes radius=51 A ˚, S-val-
ue=4.1 S; Fig. 3A, B). Addition of MVB-12 to the polycistronic
expression system resulted in a slightly larger complex with an
estimated native molecular weight of 125 kDa (Stokes ra-
dius=57.1 A ˚, S-value=5.21 S; Fig. 3C, D), nearly identical to
the predicted molecular weight of ,126 kDa for a 1:1:1:1
heterotetrameric complex of the four subunits, indicating that
addition of MVB-12 does not cause the complex to oligomerize.
On western blots of embryo extracts fractioned by gel filtration,
TSG-101 and MVB-12 peaked at similar positions, corresponding
to Stokes radii of ,57 A ˚ and 54 A ˚, respectively (Fig. 3E). The
Stokes radius of C. elegans ESCRT-I is therefore similar to that of
the heterotetrameric recombinant complex, and that previously
measured for yeast and human ESCRT-I [20,21]. TSG-101 and
MVB-12 also co-migrated on sucrose density gradients, with S-
values of ,5.0 S and 5.2 S, respectively (Fig. 3F). Together these
measurements indicate that the C. elegans ESCRT-I in extracts has
a native molecular weight of ,119 kDa, very similar to the
estimated 125 kDa molecular weight of the recombinant hetero-
tetrameric complex. We conclude that ESCRT-I is comprised of 4
subunits that form a 1:1:1:1 complex both in vivo and in vitro.
Depletion of MVB-12 slows the kinetics of receptor
downregulation but to a lesser extent than
depletion of other ESCRT-I components
Although MVB-12 forms a stoichiometric complex with the other
three ESCRT-I subunits, depletion of MVB-12, unlike depletion
of other members of the complex, does not lead to penentrant
embryonic lethality (Fig. 2B). Since depletion of the other three
ESCRT-I subunits inhibits the degradation of internalized cell
surface proteins, we wanted to determine if depletion of MVB-12
also affects this process. To characterize the effects of MVB-12
depletion, we examined the degradation of a GFP fusion with the
LDL-like receptor RME-2. Unlike GFP:CAV-1, which is variably
degraded between 30 and 90 minutes post-fertilization, the
dynamics of RME-2:GFP are highly reproducible. Within
20 min of ovulation in control zygotes, the entire population of
RME-2:GFP has been internalized from the plasma membrane,
and is observed coincident with RFP:RAB-5 positive early
endosomes en route to degradation (Fig. 4A–C). By 35 minutes
post ovulation, more than 90% of RME-2:GFP positive endo-
somes are no longer positive for RFP:RAB-5, indicating that the
RME-2:GFP has progressed beyond the early endosomal
compartment (Fig. 4D), and after an additional 30 minutes
(,65 minutes post ovulation), more than 90% of the total
RME-2:GFP fluorescence present 10 minutes post ovulation
(Fig. 4E) has been lost, indicating that the RME-2:GFP has been
largely degraded. The internalization of RME-2:GFP from the
plasma membrane occurred with relatively normal kinetics
following depletion of either TSG-101 or MVB-12, however
delays in the ability of RME-2:GFP to progress beyond RFP:RAB-
5 positive structures and in its degradation were observed for both
conditions. In TSG-101 depleted embryos, RME-2:GFP contin-
ued to localize to RFP:RAB-5 positive compartments more than
100 minutes post ovulation (Fig. 4D) and RME-2:GFP fluores-
cence was still detected more than 150 minutes post ovulation
(Fig. 4E). In contrast, depletion of MVB-12 resulted in more
moderate defects. In MVB-12 depleted embryos, the progression
of RME-2:GFP to a post RFP:RAB-5 compartment was delayed
by ,10 minutes (Fig. 4D) and an intermediate delay in RME-
2:GFP degradation was also observed (Fig. 4E). Cumulatively,
these results indicate that although MVB-12 is not essential for the
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kinetics of this process, consistent with a role for MVB-12 in
modulating ESCRT-I activity. It is interesting that inhibition of
the fourth yeast subunit, Mvb12p, also exhibits a relatively subtle
defect in comparison to loss of the other ESCRT-I subunits [17–
20], exhibiting only a partial defect in MVB sorting. These results
suggest that although the fourth yeast protein is ,3 fold smaller
and exhibits no clear sequence homolog with its metazoan
counterparts, there may be some commonalities in function
between the yeast and metazoan fourth subunits.
MVB-12 has two human homologs, MVB12A and
MVB12B
Although MVB-12 does not exhibit any sequence similarity to the
yeast ESCRT-I subunit Mvb12p, we identified a series of metazoan
homologs based on its primary sequence, including two human
proteins that we will refer to as MVB12A and MVB12B. MVB12A
and MVB12B each exhibit approximately 30% identity to MVB-12
(Fig. 5A). Previous studies have shown that overexpression of a single
ESCRT-I subunit can titrate other components of the complex and
alter endosome morphology [21]. To determine if this was also the
case for overexpression of human homologs of the fourth ESCRT-I
subunit,webeganbyexaminingtheeffectofoverexpressionofaGFP
fusion with MVB12B, introduced into HeLa cells by transient
transfection, on endosome morphology and the localization of
TSG101. In cells overexpressing GFP:MVB12B, the distribution of
TSG101 was dramatically altered, clustering around the nucleus on
membranes decorated with GFP:MVB12B (Fig. 5B). Additionally,
the morphology of these membranes was significantly different than
TSG101-positive membranes in untransfected cells (Fig. 5B). We
conclude that MVB12B can associate with other ESCRT-I
components and act in a dominant negative fashion.
The release of ESCRT-I from membranes requires the activity
of hVPS4. To test whether MVB12B also requires hVPS4
function, we examined its membrane association in cells expres-
Figure 3. ESCRT-I is a 1:1:1:1 heterotetrameric complex both in vivo and in vitro. The results presented in each panel are representative of three
individual experiments performed. Schematics in the upper right corner of each panel indicate the ESCRT-I components present in each
experiment. (A) TSG-101:6xHIS, VPS-28, and VPS-37 were co-expressed and purified from E. coli extracts using nickel resin. A Coomassie stained gel of
the peak elution fractions after fractionation of the recombinant complex on a Superose 6 gel filtration column is shown. The intensities of each band
were measured to identify the peak, and a Stokes radius was calculated for each protein based on comparison with the elution profiles of known
standards. The asterisk highlights a breakdown product of TSG-101. (B) The recombinant complex described in A, was fractionated on a 5–20%
sucrose gradient. A western blot of the fractions for TSG-101 is shown. The asterisk highlights a breakdown product of TSG-101. The intensities of
each band were measured to identify the peak, and S-values were calculated for each protein based on the location of known standards run on
a parallel gradient. (C) TSG-101:66HIS, VPS-28, VPS-37 and MVB-12 were co-expressed and purified from E. coli extracts using nickel resin. A
Coomassie stained gel of the peak elution fractions after fractionation of the recombinant complex on a Superose 6 gel filtration column is shown.
The Stokes radius of the complex, calculated as described for A, is indicated. (D) The recombinant complex described in C, was fractionated on a 5–
20% sucrose gradient. A western blot of the fractions for MVB-12 is shown. The S-value of the complex, calculated as described in B is indicated. (E)
Western blots of embryo extracts fractionated on a Superose 6 gel filtration column. The peaks corresponding to TSG-101 and MVB-12 are largely
overlapping. The Stokes radius of the complex, calculated as described for A, is indicated. (F) Western blots of embryo extracts after fractionation on
a 5–20% sucrose density gradient. TSG-101 and MVB-12 co-fractionate, both migrating with an S-value close to 5.0. The S-value of the complex,
calculated as described in B is shown.
doi:10.1371/journal.pone.0000956.g003
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mutant (E235Q) that blocks ATP hydrolysis and perturbs
endosome morphology [12,13]. While RFP:MVB12B was mostly
cytoplasmic in living HeLa cells expressing wild type
hVPS4B:GFP, expression of hVPS4B(E235Q):GFP resulted in its
accumulation on enlarged ring-like membrane compartments
(Fig. 5C). Importantly, RFP:MVB12B and hVPS4B(E235Q):GFP
co-localized on these abnormal membrane structures, indicating
that release of MVB12B from membranes requires the ATPase
activity of hVPS4 (Fig. 5C). Similar results were obtained in
experiments using RFP:MVB12A (data not shown).
To test whether MVB12A and/or MVB12B directly interact with
ESCRT-I, we immunoprecipitated either GFP:MVB12A or
GFP:MVB12B from transfected HeLa cells and probed for the
presence of TSG101. We found that TSG101 was dramatically
enriched following immunoprecipitation using GFP antibodies in
both cases, but was undetectable in control immunoprecipitations
using GST antibodies (Fig. 5D). Together, these data indicate that
Figure 4. Depletion of MVB-12 slows the degradation of internalized RME-2, but to a lesser extent than inhibition of the ESCRT-I component
TSG-101. (A) Spinning disk confocal optics were used to image control (n=7), mvb-12(RNAi) (n=8), and tsg-101(RNAi) (n=6) embryos co-expressing
RME-2:GFP and RFP:RAB-5 in utero. Representative sections are shown. Times are in minutes relative to oocyte ovulation. Arrowheads highlight the
transient accumulation of RME-2:GFP on the cell surface at the 10 min timepoint. Scale bar is 10 mm. (B) Higher magnification (2x) views of a portion
of the control images acquired in (A). At early timepoints after RME-2:GFP internalization, the GFP signal co-localizes with RFP:RAB-5. At later
timepoints, both the extent to which the localization of RME-2:GFP is co-incident with that of RFP:RAB-5 and the overall intensity of the RME-2:GFP
signal are reduced. Scale bar is 5 mm. (C) The distribution of the time (in minutes after ovulation) when the RME-2:GFP signal was no longer
detectable at the cell surface is shown for control, mvb-12(RNAi), and tsg-101(RNAi) embryos. (D) The distribution of the time (in minutes after
ovulation) when .90% of RME-2:GFP containing endosomes were no longer positive for RFP:RAB-5 is shown for control, mvb-12(RNAi), and tsg-
101(RNAi) embryos. GFP-positive and RFP-positive endosomes with signals above the cytoplasmic background were identified using individual
thresholds. At 1 min intervals, each GFP-labeled endosome was examined for RFP signal. The center of the first 5 min time interval over which less
than 10% of the total GFP-positive endosomes also had a detectable RFP signal is plotted for each embryo. (E) The distribution of the time (in minutes
after ovulation) when .90% of the RME-2:GFP fluorescence present 10 minutes post ovulation had been lost is shown for control, mvb-12(RNAi), and
tsg-101(RNAi) embryos. The total integrated RME-2:GFP fluorescence intensity was measured in a 10 mm610 mm box for each timepoint and the time
when this value fell below 10% of the total fluorescence in an identical box at the 10 min timepoint in the same embryo is plotted. Background
integrated fluorescence intensity measured in an identical box in older (.50 cell stage) control embryos was subtracted before calculating the
percentage of fluorescence remaining.
doi:10.1371/journal.pone.0000956.g004
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PLoS ONE | www.plosone.org 6 September 2007 | Issue 9 | e956Figure 5. The human MVB-12 homologs, MVB12A and MVB12B, are new components of human ESCRT-I. (A) Sequence alignment of the C. elegans
protein with MVB12A and MVB12B was performed using ClustalW. Amino acids that are identical between two of the three sequences are
highlighted in light blue and between all three sequences in dark blue. (B) HeLa cells transiently transfected with GFP:MVB12B were detergent
extracted, fixed and stained with antibodies to GFP and human TSG101 (n=23). A single section from a representative 3D computationally
deconvolved data set is shown. A color overlay of GFP:MVB12B (red) and TSG101 (green) and a higher magnification (8x) view of the indicated boxed
region are also shown. Scale bar is 10 mm. (C) HeLa cells transiently transfected with RFP:MVB12B and either wild type hVPS4B:GFP (n=13) or mutant
hVPS4B
E235Q:GFP (n=21) were imaged using spinning disk confocal microscopy. Representative color overlays of RFP:MVB12B (red) and hVPS4:GFP
(green) are also shown. Scale bar is 10 mm. (D) Immunoprecipitations with antibodies to GFP, or GST as a control, were performed on extracts
prepared from HeLa cells transfected with either GFP:MVB12A or GFP:MVB12B. Western blots of the starting extracts (load, 10% of total) and the
control (10% of total) and GFP (10% of total) immunoprecipitates were probed with antibodies to TSG101.
doi:10.1371/journal.pone.0000956.g005
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DISCUSSION
The ESCRT machinery plays a fundamental role in the turnover
of membrane bound cargo and functions to terminate receptor
signaling in multiple contexts [5]. Additionally, ESCRT-I has been
shown to be required for viral budding during HIV infection
[14,15]. Here we use C. elegans to identify and characterize a fourth
subunit of the metazoan ESCRT-I complex. In addition to the
known components TSG-101, VPS-28, and VPS-37, tandem
affinity purification of ESCRT-I from embryos followed by mass
spectrometry identified MVB-12. Like the other subunits of
ESCRT-I, MVB-12 requires TSG-101 to localize to endosomal
membranes and the AAA-type ATPase VPS-4 for its subsequent
release and recycling. A comparison of the hydrodynamic
properties of endogenous and purified recombinant ESCRT-I
indicates that MVB-12 is a stable subunit of the complex, which
exhibits a 1:1:1:1 subunit stoichiometry. Depletion of MVB-12
perturbs receptor downregulation in C. elegans, although not as
severely as other ESCRT-I subunits. Based on its primary
sequence, we also identified two human homologs of MVB-12,
both of which interact with ESCRT-I in HeLa cells and likely
define new subunits of human ESCRT-I. Our data suggest that
MVB-12 enhances ESCRT-I activity in vivo and define a potentially
new target for affecting receptor signaling and/or viral budding in
human disease.
The metazoan fourth subunits are ,3 fold larger and bear no
clear sequence similarity to the fourth subunit previously identified
in yeast. Despite our use of a common nomenclature, the
dissimilarities raise the interesting question of why three of the
ESCRT-I subunits exhibit broad conservation among eukaryotes,
whereas the fourth exhibits a high degree of divergence. Our data
suggest that there will likely be commonalities in both the way that
the divergent fourth subunits associate with the three conserved
subunits and in their function. Several lines of evidence support
this hypothesis. First, like deletion of Mvb12p which results in
a partial defect in MVB sorting that is relatively subtle in
comparison to loss of other ESCRT-I subunits [17–20], depletion
of MVB-12 delays but does not block receptor downregulation in
C. elegans, unlike the much more severe phenotype seen following
depletion of other ESCRT-I subunits. Second, both the yeast and
C. elegans ESCRT-I are heterotetrameric complexes with 1:1:1:1
subunit stoichiometries. Third, the behavior of both complexes, as
well as human ESCRT-I, during gel filtration chromatography is
similar, yielding an apparent molecular weight of 300–450 kD.
Based on structural studies, yeast ESCRT-I adopts an elongated
conformation that predicts its elution volume on the gel filtration
column [20]. The similar gel filtration elution profiles of yeast, C.
elegans and mammalian ESCRT-I would suggest that the metazoan
complex retains a similar conformation. However, a crystal
structure of the C. elegans or human ESCRT-I complex will be
necessary to determine how the larger fourth subunit is
incorporated into the ESCRT-I complex.
Despite the similarities, the dramatic divergence of a single
component of a conserved trafficking complex between fungi and
metazoans raises the possibility that the fourth subunit has evolved
unique functions in the two systems. Consistent with this idea,
MVB12A was recently identified in a proteomics screen for
substrates that are tyrosine-phosphorylated in response to
epidermal growth factor (EGF) stimulation, and was shown to
function in EGF receptor downregulation [27]. The absence of
tyrosine kinases prohibits an analogous event from occurring in
yeast. Alternatively, the fourth subunits of ESCRT-I could
function as cargo specificity factors, which would likely vary
between organisms. Consistent with this idea, loss of Mvb12p in
yeast affects the sorting of particular cargos more severely than
others [19].
Notably, mammals express two different fourth subunits that
only exhibit ,30% identity at the protein level. Similarly, four
different VPS37 isoforms, at least three of which can directly
associate with TSG101 [21,28], have been identified in mamma-
lian cells. The presence of different isoforms for multiple subunits,
combined with the 1:1:1:1 stoichiometry of the ESCRT-I
complex, indicates that mammalian cells possess a spectrum of
ESCRT-I complexes that may function in different contexts or
with alternative cargos. Further study will be necessary to uncover
the diversity and functional differences between the distinct
ESCRT-I complexes that exist in mammalian cells.
MATERIALS AND METHODS
Worm strains and DNA manipulations
The generation of C. elegans strains expressing fluorescent fusions
with RAB-5 [29], CAV-1 [23], and RME-2 [30] have been
described previously. Fluorescent fusions with MVB-12 (C06A6.3)
and VPS-37 (CD4.4) were generated by cloning the corresponding
unspliced genomic loci into the SpeI site of pIC26 (GFP
LAP; [31]).
Constructs were integrated into DP38 (unc-119 (ed3)) using a PDS-
1000/He Biolistic Particle Delivery System as previously described
[32]. All strains used in this study are listed in Table S1. C. elegans
open reading frames corresponding to components of ESCRT-I
were amplified from N2 cDNA and cloned into the polycistronic
transfer vector pET3aTr, and then into the polycistronic
expression construct pST39 [33]. A 6xHIS tag was added to the
C-terminus of TSG-101 to enable nickel affinity purification. We
thank Barth Grant (Rutgers University, Piscataway, NJ) for
providing us with a strain expressing RME-2:GFP.
RNA-mediated interference and antibody
production
dsRNA was prepared as described [34] from templates prepared
by using the primers listed in Table S2 to amplify N2 genomic
DNA. For complete depletions, L4 hermaphrodites were injected
with dsRNA and incubated at 20uC for 40–45 hours, prior to
analysis. Antibodies against TSG-101 and MVB-12 were gener-
ated by cloning nucleotides 484–948 of C09G12.9 (TSG-101) and
448–834 of C06A6.3 (MVB-12), amplified from a cDNA library,
into pGEX6P-1 (Amersham). Purified GST fusion proteins were
outsourced for injection into rabbits (Covance). Both antibodies
were affinity purified from serum as described [35] by binding to
columns of the same antigen after removal of the GST tag by
cleavage with Precision protease. Antibodies directed against
human TSG101 (Genetex) and GFP have been described
previously [31].
HeLa cell culture and microscopy
HeLa cells were grown in DME supplemented with 10% FBS,
penicillin/streptomycin, and L-glutamine (Invitrogen) at 37uCi n
a humidified atmosphere with 5% CO2. Transfections using
Effectene (Qiagen) were performed as recommended by the
manufacturer. For analysis of fixed HeLa cells, images were
acquired using a 100X, 1.35 NA Olympus U-Planapo oil objective
lens mounted on a DeltaVision system (Applied Precision) that
included an Olympus IX70 microscope equipped with a CoolSnap
CCD camera (Roper Scientific). Immunofluorescence of HeLa
cells was performed as described [21], using monoclonal a-
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live analysis, worms were anesthetized in 0.1% tricane (Sigma),
mounted on agarose pads, and imaged at 20uC on a spinning disc
confocal (Nikon Eclipse TE2000-E) microscope equipped with
a Nikon 60X, 1.4 NA Planapo oil objective lens and a Hamamatsu
Orca-ER CCD camera. Quantification of fluorescence intensity
measurements was performed using Metamorph software. HeLa
cells were grown on 35-mm glass bottom microwell dishes
(MatTek) maintained at 37uC for time-lapse imaging using
spinning disk confocal microscopy. The human VPS4 constructs
used in our studies were generously provided by Phyllis Hanson
(Washington University, St. Louis, MO).
Mass spectrometry and biochemistry
Adult hermaphrodites expressing GFP
LAP:VPS-37 were grown
synchronously in liquid culture [31] and washed in lysis buffer
(50 mM Hepes at pH 7.4, 1 mM EDTA, 1 mM MgCl2, 100 mM
KCl, and 10% glycerol). Embryos were isolated in buffer
containing 0.6 N NaOH and 20% bleach, washed with lysis
buffer, and drop frozen in liquid N2. Extracts were generated, and
VPS-37 interacting proteins isolated as described [31]. Mass
spectrometry was performed as described [36], using the most
recent version of the predicted C. elegans proteins (Wormpep111).
Protein expression in BL21 (DE3) E. coli was induced with 0.1 mM
IPTG for 3 hr at 25uC. Cells corresponding to 3 liters of culture
were lysed by sonication in 40 mLs of Lysis Buffer (50 mM Na
Phosphate [pH 8.0], 300 mM NaCl, 10 mM imidazole, 0.1%
Tween-20, 5 mM b-mercaptoethanol) and centrifuged at 20,000
RPM for 30 min at 4uC. Clarified lysates were incubated in batch
with 1 mL of Ni-NTA agarose (Qiagen) for 60 minutes. The resin
was subsequently loaded into a column, washed with 200 mL of
Lysis Buffer containing 500 mM NaCl, and eluted with buffer
containing 50 mM Na Phosphate (pH 7.0), 500 mM NaCl,
250 mM imidazole, and 5 mM b-mercaptoethanol. The eluted
protein was exchanged into buffer containing 50 mM Na
Phosphate [pH 7.0], 250 mM NaCl, 1 mM EDTA, and 1 mM
b-mercaptoethanol using an EconoPac PD10 desalting column
(BioRad) and applied to a Superose 6 gel filtration column (GE
Healthcare Life Sciences) equilibrated in the same buffer. Prior to
gel filtration, embryo extracts were similarly desalted into buffer
containing 50 mM Na Phosphate [pH 7.0], 250 mM NaCl,
1 mM EDTA, and 1 mM b-mercaptoethanol. The Stokes radius
of each protein complex was calculated from its elution volume
based on the elution profiles of standards of known stokes radii
(chymotrypsin A, ovalbumin, aldolase, catalase, ferritin and
thyroglobulin) run on the same column. Sucrose gradients (5–
20%) were poured as previously described [37] and fractionated
from the top by hand. Sedimentation values were calculated by
comparing the position of the peak with that of standards of known
S-value (bovine serum albumin, aldolase, catalase, and thyroglob-
ulin) run on a separate gradient processed in parallel. Immuno-
blotting of extracts and immunoprecipitations were performed as
described [36].
SUPPORTING INFORMATION
Table S1
Found at: doi:10.1371/journal.pone.0000956.s001 (0.02 MB
DOC)
Table S2
Found at: doi:10.1371/journal.pone.0000956.s002 (0.03 MB
DOC)
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